Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
JACC. Advances
|
October 7, 2024
Evolution or Revolution?: AI in Coronary CT Evaluation
Kelley R H Branch
JACC. Cardiovascular Imaging
|
October 8, 2025
Observe, Treat, Adhere: Interactions of CT Coronary Artery Disease, Lipid-Lowering Adherence, and Cardiovascular Events
Kelley R H Branch, Sumeet Brar
European Heart Journal. Cardiovascular Imaging
|
August 18, 2022
Coronary plaque in the fourth dimension: associating coronary computed tomography plaque components and the time to acute coronary syndrome
Jay Voit, Kelley R H Branch
The New England Journal of Medicine
|
March 30, 2026
Paving the Road toward Targeted Lipid Lowering
Jeffrey L Probstfield, Kelley R H Branch
Chest
|
July 8, 2026
Scanning for the Full Picture: Building Evidence for Imaging After In-Hospital Cardiac Arrest
Nicholas J Johnson, Kelley R H Branch
European Journal of Heart Failure
|
October 12, 2022
Reply to the letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial'
Kelley R H Branch, Hertzel C Gerstein, Jeffrey L Probstfield
Resuscitation
|
November 30, 2024
Lung parenchymal and pleural findings on computed tomography after out-of-hospital cardiac arrest
Maranda Newton, Jane Hall, Catherine R Counts, et al.
Diabetes Care
|
June 9, 2025
Effect of Efpeglenatide on Heart Failure Outcomes: A Participant-Level Exploratory Analysis of the Randomized AMPLITUDE-O Trial
Kelley R H Branch, Carolyn S P Lam, Shofiqul Islam, et al.
Cardiovascular Diabetology
|
September 28, 2024
Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial
Stefano Del Prato, Zhuoru Li, Chinthanie Ramasundarahettige, et al.
Diabetes, Obesity & Metabolism
|
December 20, 2023
Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial
Hertzel C Gerstein, Rajibul Mian, Chinthanie Ramasundarahettige, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
JACC. Advances
|
October 7, 2024
Evolution or Revolution?: AI in Coronary CT Evaluation
Kelley R H Branch
JACC. Cardiovascular Imaging
|
October 8, 2025
Observe, Treat, Adhere: Interactions of CT Coronary Artery Disease, Lipid-Lowering Adherence, and Cardiovascular Events
Kelley R H Branch, Sumeet Brar
European Heart Journal. Cardiovascular Imaging
|
August 18, 2022
Coronary plaque in the fourth dimension: associating coronary computed tomography plaque components and the time to acute coronary syndrome
Jay Voit, Kelley R H Branch
The New England Journal of Medicine
|
March 30, 2026
Paving the Road toward Targeted Lipid Lowering
Jeffrey L Probstfield, Kelley R H Branch
Chest
|
July 8, 2026
Scanning for the Full Picture: Building Evidence for Imaging After In-Hospital Cardiac Arrest
Nicholas J Johnson, Kelley R H Branch
European Journal of Heart Failure
|
October 12, 2022
Reply to the letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial'
Kelley R H Branch, Hertzel C Gerstein, Jeffrey L Probstfield
Resuscitation
|
November 30, 2024
Lung parenchymal and pleural findings on computed tomography after out-of-hospital cardiac arrest
Maranda Newton, Jane Hall, Catherine R Counts, et al.
Diabetes Care
|
June 9, 2025
Effect of Efpeglenatide on Heart Failure Outcomes: A Participant-Level Exploratory Analysis of the Randomized AMPLITUDE-O Trial
Kelley R H Branch, Carolyn S P Lam, Shofiqul Islam, et al.
Cardiovascular Diabetology
|
September 28, 2024
Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial
Stefano Del Prato, Zhuoru Li, Chinthanie Ramasundarahettige, et al.
Diabetes, Obesity & Metabolism
|
December 20, 2023
Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial
Hertzel C Gerstein, Rajibul Mian, Chinthanie Ramasundarahettige, et al.
Page
of 4